| 10-Oct-2025 10:04 |
85.00p |
23,000 |
£19,550 |
Buy |
O |
| 10-Oct-2025 09:00 |
83.00p |
20,000 |
£16,600 |
Sell |
TK |
| 10-Oct-2025 09:00 |
83.00p |
19,683 |
£16,337 |
Sell |
|
| 10-Oct-2025 11:00 |
84.49p |
4,734 |
£4,000 |
Buy |
O |
| 10-Oct-2025 08:00 |
83.00p |
4,559 |
£3,784 |
Unknown |
|
| 10-Oct-2025 08:00 |
83.00p |
4,559 |
£3,784 |
Unknown |
UT |
| 10-Oct-2025 12:37 |
84.70p |
3,100 |
£2,626 |
Buy |
O |
| 10-Oct-2025 09:29 |
84.49p |
2,259 |
£1,909 |
Buy |
O |
| 10-Oct-2025 10:40 |
84.10p |
1,307 |
£1,099 |
Buy |
O |
| 10-Oct-2025 08:23 |
84.49p |
1,183 |
£1,000 |
Buy |
O |
| 10-Oct-2025 11:00 |
83.00p |
758 |
£629 |
Sell |
|
| 10-Oct-2025 11:00 |
83.00p |
758 |
£629 |
Sell |
TK |
| 10-Oct-2025 09:00 |
83.00p |
317 |
£263 |
Sell |
|
| 10-Oct-2025 08:54 |
84.93p |
117 |
£99 |
Buy |
O |
| 14:25 |
2,265 @ 83.20p |
| 12:21 |
1,779 @ 83.20p |
| CEO |
Daniel Adam Rabie |
| CFO |
Paul Haworth |
Top of Page
You are here:
research